Xenon Pharmaceuticals (XENE) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free XENE Stock Alerts $38.07 -0.97 (-2.48%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Xenon Pharmaceuticals Short Interest DataCurrent Short Interest2,820,000 sharesPrevious Short Interest2,790,000 sharesChange Vs. Previous Month+1.08%Dollar Volume Sold Short$114.07 millionShort Interest Ratio8.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares75,470,000 sharesPercentage of Shares Shorted3.74%Today's Trading Volume778,149 sharesAverage Trading Volume307,587 sharesToday's Volume Vs. Average253% Short Selling Xenon Pharmaceuticals ? Sign up to receive the latest short interest report for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXENE Short Interest Over TimeXENE Days to Cover Over TimeXENE Percentage of Float Shorted Over Time Ad Behind the MarketsLEAKED: Jeff Bezos' $330 Million GambleDid you know that 3 simple words are disrupting a $62.7 billion market? "Blood Brain Barrier" Seems innocent enough.Here's how you could invest alongside them >>> Xenon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,820,000 shares $114.07 million +1.1%N/A8 $40.45 4/30/20242,790,000 shares $113.41 million +6.5%N/A7.8 $40.65 4/15/20242,620,000 shares $108.23 million -5.1%N/A7.3 $41.31 3/31/20242,760,000 shares $118.82 million +5.3%N/A7 $43.05 3/15/20242,620,000 shares $115.18 million -3.0%N/A5.7 $43.96 2/29/20242,700,000 shares $127.44 million +6.7%N/A5.3 $47.20 Get the Latest News and Ratings for XENE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20242,530,000 shares $123.19 million -10.0%N/A4.2 $48.69 1/31/20242,810,000 shares $127.07 million +12.0%N/A4.2 $45.22 1/15/20242,510,000 shares $113.18 million +13.1%N/A3.6 $45.09 12/31/20232,220,000 shares $102.25 million -5.9%N/A3.3 $46.06 12/15/20232,360,000 shares $97.73 million +20.4%N/A3.6 $41.41 11/30/20231,960,000 shares $71.70 million +14.6%N/A3.3 $36.58 11/15/20231,710,000 shares $49.85 million -2.8%N/A3.4 $29.15 10/31/20231,760,000 shares $54.56 million -10.2%N/A4.2 $31.00 10/15/20231,960,000 shares $68.87 million -26.3%N/A5.2 $35.14 9/30/20232,660,000 shares $90.87 million -4.0%N/A7.2 $34.16 9/15/20232,770,000 shares $102.10 million -0.4%N/A8.6 $36.86 8/31/20232,780,000 shares $108.36 million +2.2%N/A8.5 $38.98 8/15/20232,720,000 shares $101.62 million +2.6%N/A7.8 $37.36 7/31/20232,650,000 shares $97.84 million -4.3%N/A7.8 $36.92 7/15/20232,770,000 shares $107.61 million -10.9%N/A7.7 $38.85 6/30/20233,110,000 shares $119.74 million -2.8%N/A8.6 $38.50 6/15/20233,200,000 shares $134.50 million +9.6%N/A8.3 $42.03 5/31/20232,920,000 shares $112.51 million -3.6%N/A7.5 $38.53 5/15/20233,030,000 shares $126.47 million -12.2%N/A7.5 $41.74 4/30/20233,450,000 shares $138.97 million -1.2%N/A8.5 $40.28 4/15/20233,490,000 shares $124.24 million -11.4%N/A9 $35.60 3/31/20233,940,000 shares $141.01 million +7.7%N/A9.8 $35.79 3/15/20233,660,000 shares $124.37 million +16.2%N/A9.3 $33.98 2/28/20233,150,000 shares $124.30 million +2.9%N/A8.1 $39.46 2/15/20233,060,000 shares $118.76 million +1.0%N/A8.3 $38.81 1/31/20233,030,000 shares $118.44 million -16.5%N/A8 $39.09 1/15/20233,630,000 shares $131.41 million +1.4%N/A9.5 $36.20 12/30/20223,580,000 shares $141.16 million -6.3%N/A9.6 $39.43 12/15/20223,820,000 shares $145.81 million +2.4%N/A10.4 $38.17 11/30/20223,730,000 shares $137.56 million +1.4%N/A10.7 $36.88 11/15/20223,680,000 shares $128.03 million +4.8%N/A10.3 $34.79 10/31/20223,510,000 shares $128.36 million +9.0%N/A9 $36.57 10/15/20223,220,000 shares $111.64 million +15.8%N/A8.2 $34.67 9/30/20222,780,000 shares $100.36 million +7.3%N/A6.9 $36.10This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 9/15/20222,590,000 shares $101.79 million +9.8%N/A5.9 $39.30 8/31/20222,360,000 shares $91.59 million +28.3%N/A4.6 $38.81 8/15/20221,840,000 shares $69.13 million -17.5%N/A3.5 $37.57 7/31/20222,230,000 shares $73.92 million -5.9%N/A4.2 $33.15 7/15/20222,370,000 shares $76.29 million +6.8%N/A4.5 $32.19 6/30/20222,220,000 shares $67.53 million -7.9%N/A4.1 $30.42 6/15/20222,410,000 shares $69.43 million -2.0%N/A4.3 $28.81 5/31/20222,460,000 shares $64.82 million -6.1%N/A5.2 $26.35 5/15/20222,620,000 shares $78.02 million +30.4%N/A5.7 $29.78 4/30/20222,010,000 shares $56.82 million -6.5%N/A4.8 $28.27 4/15/20222,150,000 shares $72.61 million -0.9%N/A5.2 $33.77 3/31/20222,170,000 shares $66.34 million -4.4%N/A4.6 $30.57 3/15/20222,270,000 shares $63.72 million +0.4%N/A5.6 $28.07 2/28/20222,260,000 shares $71.64 million +3.2%N/A5.4 $31.70 2/15/20222,190,000 shares $71.81 million +5.3%N/A4.9 $32.79 1/31/20222,080,000 shares $56.41 million +11.8%N/A4.3 $27.12 1/15/20221,860,000 shares $59.45 million +5.1%N/A3.6 $31.96 12/31/20211,770,000 shares $55.29 million -16.5%N/A3.1 $31.24 12/15/20212,120,000 shares $56.33 million +26.2%N/A1 $26.57 11/30/20211,680,000 shares $44.86 million -7.2%N/A0.8 $26.70 11/15/20211,810,000 shares $57.34 million +5.9%N/A0.9 $31.68 10/29/20211,710,000 shares $53.27 million -13.6%N/A0.8 $31.15 10/15/20211,980,000 shares $66.65 million +121.6%N/A1 $33.66 9/30/2021893,500 shares $13.65 million +52.4%N/A0.5 $15.28 9/15/2021586,400 shares $10.13 million +10.5%1.6%3.1 $17.28 8/31/2021530,600 shares $9.37 million -20.4%1.4%2.8 $17.65 8/13/2021666,500 shares $12.30 million -6.9%1.8%3.5 $18.45 7/30/2021715,700 shares $12.36 million -0.3%2.0%3.9 $17.27 7/15/2021717,700 shares $12.70 million +12.1%1.8%4.3 $17.69 6/30/2021640,500 shares $11.93 million +0.7%1.6%3.5 $18.62 6/15/2021636,100 shares $11.44 million -3.2%1.7%3.5 $17.99 5/28/2021657,400 shares $12.14 million -13.5%1.8%4.2 $18.47 5/14/2021759,600 shares $12.77 million -3.4%N/A3.9 $16.81 4/30/2021786,600 shares $14.40 million +0.5%N/A4.3 $18.31 4/15/2021782,900 shares $15.25 million +5.8%N/A3.8 $19.48 3/31/2021739,700 shares $12.94 million -13.8%N/A4 $17.49 3/15/2021858,200 shares $17.64 million -9.1%N/A4.2 $20.55 2/26/2021943,900 shares $17.10 million -3.4%N/A5.3 $18.12 2/12/2021977,100 shares $14.72 million -5.1%N/A5.9 $15.07 1/29/20211,030,000 shares $15.30 million -3.7%N/A6.4 $14.85 1/15/20211,070,000 shares $16.65 million -6.1%N/A6.8 $15.56 12/31/20201,140,000 shares $18.29 million +36.4%N/A8.1 $16.04 12/15/2020835,600 shares $10.11 million +0.8%N/A6.1 $12.10 11/30/2020829,400 shares $9.46 million +2.9%N/A7.6 $11.40 10/30/2020720,700 shares $6.93 million -45.0%N/A6.8 $9.62 10/15/20201,310,000 shares $14.63 million -4.4%N/A13.3 $11.17 9/30/20201,370,000 shares $15.17 million -0.7%N/A13.1 $11.07 9/15/20201,380,000 shares $15.18 million -0.7%N/A13.2 $11.00 8/31/20201,390,000 shares $16.89 million +14.9%N/A9.9 $12.15 8/14/20201,210,000 shares $13.09 million +7.1%N/A6.5 $10.82This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 7/31/20201,130,000 shares $12.35 million +9.7%N/A6.1 $10.93 7/15/20201,030,000 shares $12.39 million +12.3%N/A5.4 $12.03 6/30/2020917,600 shares $11.02 million +16.7%N/A4.4 $12.01 6/15/2020786,100 shares $9.44 million +5.8%N/A3.2 $12.01 5/29/2020742,700 shares $9.43 million -0.1%N/A2.9 $12.70 5/15/2020743,600 shares $9.46 million +2.7%N/A3.2 $12.72 4/30/2020723,800 shares $9.38 million +8.5%N/A2.8 $12.96 4/15/2020667,400 shares $9.31 million +18.6%N/A2.4 $13.95 3/31/2020562,700 shares $6.38 million -4.8%N/A1.8 $11.34 3/13/2020591,300 shares $7.60 million +29.8%2.6%2.3 $12.86 2/28/2020455,400 shares $4.56 million +9.7%2.0%1.7 $10.01 2/14/2020415,300 shares $5.34 million +1.1%N/A1.5 $12.86 1/31/2020410,900 shares $5.66 million +4.2%1.7%1.7 $13.77 1/15/2020394,200 shares $6.07 million -8.3%1.6%1.8 $15.40 12/31/2019429,800 shares $6.66 million -24.4%2.1%2.4 $15.50 XENE Short Interest - Frequently Asked Questions What is Xenon Pharmaceuticals' current short interest? Short interest is the volume of Xenon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 2,820,000 shares of XENE short. Learn More on Xenon Pharmaceuticals' current short interest. What is a good short interest ratio for Xenon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XENE shares currently have a short interest ratio of 8.0. Learn More on Xenon Pharmaceuticals's short interest ratio. Which institutional investors are shorting Xenon Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Xenon Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Xenon Pharmaceuticals' short interest increasing or decreasing? Xenon Pharmaceuticals saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 2,820,000 shares, an increase of 1.1% from the previous total of 2,790,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Xenon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Xenon Pharmaceuticals: Supernus Pharmaceuticals, Inc. (9.33%), Sage Therapeutics, Inc. (17.10%), Voyager Therapeutics, Inc. (7.98%), Marinus Pharmaceuticals, Inc. (8.90%), Sarepta Therapeutics, Inc. (6.94%), Catalent, Inc. (3.76%), Roivant Sciences Ltd. (7.02%), Elanco Animal Health Incorporated (3.43%), Legend Biotech Co. (7.12%), Cerevel Therapeutics Holdings, Inc. (8.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Xenon Pharmaceuticals stock? Short selling XENE is an investing strategy that aims to generate trading profit from Xenon Pharmaceuticals as its price is falling. XENE shares are trading down $0.97 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xenon Pharmaceuticals? A short squeeze for Xenon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XENE, which in turn drives the price of the stock up even further. How often is Xenon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XENE, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SUPN Short Interest Data SAGE Short Interest Data VYGR Short Interest Data MRNS Short Interest Data SRPT Short Interest Data CTLT Short Interest Data ROIV Short Interest Data ELAN Short Interest Data LEGN Short Interest Data CERE Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XENE) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.